We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGS
4676
DELISTED
PlayAGS
AGS
$6K ﹤0.01%
1,080
-428
-28% -$2.41K
AMZA icon
4677
InfraCap MLP ETF
AMZA
$477M
$6K ﹤0.01%
187
+6
+3% +$191
ASYS icon
4678
Amtech Systems
ASYS
$279M
$6K ﹤0.01%
836
-793
-49% -$7.18K
AVAV icon
4679
AeroVironment
AVAV
$9.59B
$6K ﹤0.01%
73
-3,907
-98% -$334K
AYTU icon
4680
AYTU BioPharma
AYTU
$25.3M
$6K ﹤0.01%
1,613
-892
-36% -$3.36K
BDTX icon
4681
Black Diamond Therapeutics
BDTX
$121M
$6K ﹤0.01%
3,465
-810
-19% -$1.46K
KEEL
4682
Keel Infrastructure Corp
KEEL
$2.04B
$6K ﹤0.01%
14,486
-21,099
-59% -$15.5K
BIV icon
4683
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$6K ﹤0.01%
78
BLV icon
4684
Vanguard Long-Term Bond ETF
BLV
$5.73B
$6K ﹤0.01%
89
-300
-77% -$21.7K
BMRA icon
4685
Biomerica
BMRA
$4.85M
$6K ﹤0.01%
+209
New +$6K
SRXH
4686
SRX Global
SRXH
$35.9M
$6K ﹤0.01%
6
+4
+200% +$6.57K
BWMN icon
4687
Bowman Consulting
BWMN
$732M
$6K ﹤0.01%
278
-859
-76% -$15K
BYFC icon
4688
Broadway Financial
BYFC
$105M
$6K ﹤0.01%
794
-243
-23% -$1.99K
CACC icon
4689
Credit Acceptance
CACC
$5.99B
$6K ﹤0.01%
13
-849
-98% -$390K
CDC icon
4690
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$753M
$6K ﹤0.01%
94
-23
-20% -$1.44K
CHKP icon
4691
Check Point Software Technologies
CHKP
$13.2B
$6K ﹤0.01%
48
-1,416
-97% -$177K
CKX icon
4692
CKX Lands
CKX
$22.4M
$6K ﹤0.01%
+600
New +$6.39K
CLPT icon
4693
ClearPoint Neuro
CLPT
$463M
$6K ﹤0.01%
706
-7,788
-92% -$73.8K
CMCO icon
4694
Columbus McKinnon
CMCO
$557M
$6K ﹤0.01%
204
-6,433
-97% -$190K
CMPX icon
4695
Compass Therapeutics
CMPX
$407M
$6K ﹤0.01%
+1,160
New +$4.63K
CNTX icon
4696
Context Therapeutics
CNTX
$46.5M
$6K ﹤0.01%
8,857
+1,558
+21% +$1.68K
CRBP icon
4697
Corbus Pharmaceuticals
CRBP
$189M
$6K ﹤0.01%
1,885
+1,638
+663% +$6.3K
CREX icon
4698
Creative Realities
CREX
$39.3M
$6K ﹤0.01%
3,398
-131
-4% -$240
CRNT icon
4699
Ceragon Networks
CRNT
$201M
$6K ﹤0.01%
3,126
-13,328
-81% -$25K
CTGO icon
4700
Contango Silver & Gold Inc
CTGO
$657M
$6K ﹤0.01%
282
+72
+34% +$1.85K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.